CD8+ T cells may also inhibit or prevent cancer progression by favoring the intratumoral recruitment of immune effectors including neutrophils, macrophages and NK cells, promoting the amplification of the in situ anti-tumor immune responses [9-11]. Here, CD8A is linked to neoplasm.